Date | Title | Description | Source |
02.02.2024 |
Tyra Bioscienes Scores $200M In PIPE
| Carlsbad-based Tyra Biosciences ,a company developing precision medicines for targeting Fibroblast G... | socaltech.... |
03.11.2021 | Tyra Biosciences Reports Third Quarter 2021 Financial Result... | CARLSBAD, Calif., Nov. 3, 2021 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision on... | marketscre... |
14.10.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
13.10.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
11.10.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
10.10.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
09.10.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
08.10.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
07.10.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
03.10.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
02.10.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
29.09.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
26.09.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
23.09.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
22.09.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
21.09.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
20.09.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
17.09.2021 | Tyra Announces Closing of Initial Public Offering and Full E... | CARLSBAD, Calif., Sept. 17, 2021 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision ... | marketscre... |
15.09.2021 | Tyra Biosciences closes IPO for $172.8M | - | connect.or... |
15.09.2021 | Tyra Announces Pricing of Upsized Initial Public Offering | CARLSBAD, Calif., Sept. 14, 2021 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision ... | marketscre... |
15.09.2021 | Dice’s IPO roll comes up with $204M for R&D of oral drug... | Biologic drugs offer quite the punch, treating a wide swath of immunological disorders for patients ... | medcitynew... |
31.03.2021 | Tyra Biosciences, Inc. announced that it has received $106 m... | Tyra Biosciences, Inc. announced that it has raised $106 million in a round of funding led by new in... | marketscre... |
31.03.2021 | Tyra Biosciences banks $106M, adds to C-suite as it aims for... | Tyra Biosciences raised $50 million in early 2020 to get the ball rolling on a pipeline against drug... | fiercebiot... |
31.03.2021 | Tyra Biosciences banks $106M, adds to C-suite as it aims for... | Tyra Biosciences raised $50 million in early 2020 to get the ball rolling on a pipeline against drug... | fiercebiot... |
28.01.2020 | Tyra Biosciences Raises $50 Million In Cancer Fight | Tyra Biosciences, a Carlsbad company that wants to combat cancers that become drug-resistant, has ra... | sdbj.com/n... |
13.01.2020 | Tyra Biosciences Raises USD 50M in Series A Funding | Tyra Biosciences, a Carlsbad, Calif.-based company discovering and developing new small molecule the... | finsmes.co... |
10.01.2020 | Tyra Biosciences takes aim at treatment-resistant tumors wit... | Targeted therapies have changed the face of treatment for many cancers, such as those with EGFR or A... | fiercebiot... |
10.01.2020 | Tyra Biosciences takes aim at treatment-resistant tumors wit... | Targeted therapies have changed the face of treatment for many cancers, such as those with EGFR or A... | fiercebiot... |
10.01.2020 | Tyra Biosciences raises $50M to develop therapies targeting ... | - | connect.or... |
- | FierceBiotech: Tyra Biosciences takes aim at treatment-resis... | - | canaan.com... |
- | Dice’s IPO roll comes up with $204M for R&D of oral drug... | Biologic drugs offer quite the punch, treating a wide swath of immunological disorders for patients ... | medcitynew... |